Abbott Laboratories (BVMF:ABTT34)

Abbott Laboratories Ratios and Metrics

Market cap in millions BRL. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 11, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	1,239,253	1,213,380	927,216	1,011,998	1,344,811	974,246
Market Cap Growth	28.48%	30.86%	-8.38%	-24.75%	38.04%	57.79%
Enterprise Value	1,273,494	1,259,705	970,232	1,048,380	1,394,516	1,047,163
Last Close Price	59.10	57.36	43.75	46.88	62.14	44.23
PE Ratio	16.33	14.69	33.52	27.72	34.28	41.94
PS Ratio	5.28	4.68	4.76	4.39	5.60	5.42
PB Ratio	4.47	4.10	4.92	5.19	6.70	5.68
P/TBV Ratio	10.99	10.96	31.28	55.76	-	-
P/FCF Ratio	-	30.89	37.77	24.53	27.91	32.77
P/OCF Ratio	-	22.92	26.32	19.98	22.92	23.74
EV/Sales Ratio	5.57	4.86	4.99	4.54	5.81	5.83
EV/EBITDA Ratio	20.30	19.01	19.11	16.02	19.64	22.94
EV/EBIT Ratio	28.87	27.17	27.69	21.76	27.19	36.92
EV/FCF Ratio	34.50	32.07	39.52	25.41	28.94	35.23
Debt / Equity Ratio	0.27	0.32	0.41	0.49	0.53	0.60
Debt / EBITDA Ratio	1.14	1.38	1.48	1.41	1.47	2.18
Debt / FCF Ratio	1.99	2.41	3.16	2.30	2.23	3.48
Asset Turnover	0.55	0.54	0.54	0.58	0.58	0.49
Inventory Turnover	2.74	2.92	2.81	3.37	3.56	3.22
Quick Ratio	1.14	1.05	1.00	1.06	1.28	1.14
Current Ratio	1.82	1.67	1.64	1.63	1.85	1.72
Return on Equity (ROE)	30.93%	30.91%	15.11%	19.01%	20.49%	13.91%
Return on Assets (ROA)	6.62%	6.06%	6.11%	7.61%	7.79%	4.86%
Return on Capital (ROIC)	8.75%	7.94%	8.23%	10.34%	10.64%	6.61%
Return on Capital Employed (ROCE)	11.80%	11.10%	12.20%	15.50%	14.80%	9.00%
Earnings Yield	6.12%	6.83%	3.00%	3.62%	2.93%	2.40%
FCF Yield	2.98%	3.24%	2.65%	4.08%	3.58%	3.05%
Dividend Yield	1.25%	24.15%	23.07%	21.65%	16.32%	17.96%
Payout Ratio	28.42%	28.62%	62.13%	47.73%	45.28%	56.95%
Buyback Yield / Dilution	0.08%	0.06%	0.85%	1.40%	-0.17%	-0.28%
Total Shareholder Return	1.32%	24.21%	23.92%	23.05%	16.15%	17.68%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.